discussions < disease < diseases

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by disease

Number of relevant bibliographic references: 954.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000000 (2021)	Aniruddha Singh [États-Unis] ; Muhammad S. Akbar [États-Unis] ; Doug Mcelroy [États-Unis] ; Matthew Mccurdy [États-Unis] ; Fletcher Young [États-Unis] ; Jayshree Thomas [États-Unis] ; Chrystie Nguyen [États-Unis] ; Kristopher S. Pfirman [États-Unis]	The electrocardiographic manifestations and derangements of 2019 novel coronavirus disease (COVID-19).
000009 (2021)	Rashed Noor [Bangladesh]	Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.
000010 (2021)	Nicole Fagan [Irlande (pays)] ; Nekma Meah [Australie] ; Katherine York [Afrique du Sud] ; Laita Bokhari [Australie] ; Godfrey Fletcher [Irlande (pays)] ; Gang Chen [Australie] ; Desmond J. Tobin [Irlande (pays)] ; Andrew Messenger [Royaume-Uni] ; Alan D. Irvine [Irlande (pays)] ; Rodney Sinclair [Australie] ; Dmitri Wall [Irlande (pays)]	Shedding light on therapeutics in alopecia and their relevance to COVID-19.
000022 (2021)	E. Díaz [Espagne] ; R. Amézaga Menéndez [Espagne] ; P. Vidal Cortés [Espagne] ; M G Escapa [Espagne] ; B. Suberviola [Espagne] ; A. Serrano Lázaro [Espagne] ; P. Marcos Neira [Espagne] ; M. Quintana Díaz [Espagne] ; M. Catalán González [Espagne]	[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].
000023 (2021)	Consuelo Luna-Mu Oz [Pérou] ; Giuliana Reyes-Florian [Pérou] ; Martin Seminario-Aliaga [Pérou] ; Angie Stapleton-Herbozo [Pérou] ; Lucy E. Correa-L Pez [Pérou] ; Dante M. Qui Ones-Laveriano [Pérou]	[Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital].
000031 (2021)	Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie]	Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
000033 (2021)	Dania Altulea [Pays-Bas] ; Sjors Maassen [Pays-Bas] ; Maksim V. Baranov [Pays-Bas] ; Geert Van Den Bogaart [Pays-Bas]	What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
000035 (2021)	L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A Marcialis	What if COVID-19 affects the child: which weapons and how to use them.
000046 (2021)	Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil]	Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
000047 (2021)	Juliana Cepelowicz Rajter [États-Unis] ; Michael S. Sherman [États-Unis] ; Naaz Fatteh [États-Unis] ; Fabio Vogel [États-Unis] ; Jamie Sacks [États-Unis] ; Jean-Jacques Rajter [États-Unis]	Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.
000049 (2021)	Boghuma K. Titanji [États-Unis] ; Monica M. Farley [États-Unis] ; Ashish Mehta [États-Unis] ; Randi Connor-Schuler [États-Unis] ; Abeer Moanna [États-Unis] ; Sushma K. Cribbs [États-Unis] ; Jesse O'Shea [États-Unis] ; Kathryn Desilva [États-Unis] ; Bonnie Chan [États-Unis] ; Alex Edwards [États-Unis] ; Christina Gavegnano [États-Unis] ; Raymond F. Schinazi [États-Unis] ; Vincent C. Marconi [États-Unis]	Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019.
000051 (2021)	Tahani Bin Ali ; Ghaleb Elyamany ; Maha Nojoom ; Mohamed Alfaki ; Hassan Alahmari ; Abdulwahab Alharthi ; Muwaffak Hijazi ; Atif Alsahari ; Fahad Alabbas ; Abdulnasir Al-Otaibi [Arabie saoudite]	Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction.
000056 (2021)	Jessica S C. Leung [Hong Kong] ; Maurice M W. Cheng [Nouvelle-Zélande]	Trust in the time of corona: epistemic practice beyond hard evidence.
000061 (2021)	Neils Ben Quashie [Ghana] ; Nancy Odurowah Duah-Quashie [Ghana]	Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries.
000063 (2021)	Jennie H. Best [États-Unis] ; Amanda M. Kong [États-Unis] ; Emma Kaplan-Lewis [États-Unis] ; Otis W. Brawley [États-Unis] ; Rachel Baden [États-Unis] ; James L. Zazzali [États-Unis] ; Karen S. Miller [États-Unis] ; James Loveless [États-Unis] ; Krutika Jariwala-Parikh [États-Unis] ; Shalini V. Mohan [États-Unis]	Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement.
000070 (2021)	Bagrat Lalabekyan [Royaume-Uni] ; Gudrun Kunst [Royaume-Uni] ; Vanessa A. Skelton [Royaume-Uni]	Torsades de Pointes in Coronavirus Disease 2019 Infection.
000075 (2021)	Sawsan Elgohary [Égypte] ; Aya A. Elkhodiry [Égypte] ; Nada S. Amin [Égypte] ; Ulrike Stein [Allemagne] ; Hend M. El Tayebi [Égypte]	Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
000077 (2021)	Muhammad Sani Ismaila [Trinité-et-Tobago] ; Faruku Bande [Nigeria] ; Aminu Ishaka [Nigeria] ; Aminatu Abubakar Sani [Nigeria] ; Karla Georges [Trinité-et-Tobago]	Therapeutic options for COVID-19: a quick review.
000082 (2021)	Yifei Wang [République populaire de Chine] ; Jingbin Zheng [République populaire de Chine] ; Md Sahidul Islam [République populaire de Chine] ; Yang Yang [République populaire de Chine] ; Yuanjia Hu [République populaire de Chine] ; Xin Chen [République populaire de Chine]	The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.
000083 (2021)	Nurdan Kokturk [Turquie] ; Cenk Babayigit [Turquie] ; Seval Kul [Turquie] ; Pelin Duru Cetinkaya [Turquie] ; Sibel Atis Nayci [Turquie] ; Serap Argun Baris [Turquie] ; Oguz Karcioglu [Turquie] ; Pinar Aysert [Turquie] ; Ilim Irmak [Turquie] ; Aycan Akbas Yuksel [Turquie] ; Yonca Sekibag [Turquie] ; Oya Baydar Toprak [Turquie] ; Emel Azak [Oman] ; Sait Mulamahmutoglu [Turquie] ; Caglar Cuhadaroglu [Turquie] ; Aslihan Demirel [Turquie] ; Bugra Kerget [Turquie] ; Burcu Baran Ketencioglu [Turquie] ; Hasan Selcuk Ozger [Turquie] ; Gulcihan Ozkan [Turquie] ; Zeynep Ture [Turquie] ; Begum Ergan [Turquie] ; Vildan Avkan Oguz [Turquie] ; Oguz Kilinc [Turquie] ; Merve Ercelik [Turquie] ; Tansu Ulukavak Ciftci [Turquie] ; Ozlem Alici [Turquie] ; Esra Nurlu Temel [Turquie] ; Ozlem Ataoglu [Turquie] ; Asena Aydin [Turquie] ; Dilek Cetiner Bahcetepe [Turquie] ; Yusuf Taha Gullu [Turquie] ; Fusun Fakili [Turquie] ; Figen Deveci [Turquie] ; Neslihan Kose [Turquie] ; Muge Meltem Tor [Turquie] ; Gulsah Gunluoglu [Turquie] ; Sedat Altin [Turquie] ; Teyfik Turgut [Turquie] ; Tibel Tuna [Turquie] ; Onder Ozturk [Turquie] ; Oner Dikensoy [Turquie] ; Pinar Yildiz Gulhan [Turquie] ; Ilknur Basyigit [Turquie] ; Hasim Boyaci [Turquie] ; I Kivilcim Oguzulgen [Turquie] ; Sermin Borekci [Turquie] ; Bilun Gemicioglu [Turquie] ; Firat Bayraktar [Turquie] ; Osman Elbek [Turquie] ; Ismail Hanta [Turquie] ; Hacer Kuzu Okur [Turquie] ; Gulseren Sagcan [Turquie] ; Oguz Uzun [Turquie] ; Metin Akgun [Turquie] ; Goksel Altinisik [Turquie] ; Berna Dursun [Turquie] ; Ebru Cakir Edis [Turquie] ; Erkmen Gulhan [Turquie] ; Fusun Oner Eyuboglu [Turquie] ; Okkes Gultekin [Turquie] ; Yavuz Havlucu [Turquie] ; Metin Ozkan [Turquie] ; Aysin Sakar Coskun [Turquie] ; Abdullah Sayiner [Turquie] ; Ali Fuat Kalyoncu [Turquie] ; Oya Itil [Turquie] ; Hasan Bayram [Turquie]	The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.
000084 (2021)	Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis]	The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "disease" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "disease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    disease
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021